Patients with Obesity Call for Fair Drug Standards: New Research Reveals Strong Demand for FDA and Industry Action on Testing and Labeling
At ObesityWeek 2025, new data show overwhelming public support for ensuring that all medications are evaluated and labeled for safety and efficacy in people with obesity. New research presented today at ObesityWeek 2025, the world's leading international conference on obesity science and care, shows that people with obesity overwhelmingly expect the U.S. Food and Drug […]